Jupiter Asset Management’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Jupiter Asset Management’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-100,865	Closed	-$1.06M	–	217
2016 Q1	$1.06M	Buy	100,865 +9,994	+11%	+$199K	0.04%	200
2015 Q4	$2.68M	Hold	90,871	–	–	0.1%	178
2015 Q3	$2.87M	Buy	90,871 +7,445	+9%	+$356K	0.11%	167
2015 Q2	$4.94M	Buy	83,426 +47,498	+132%	+$3.35M	0.17%	148
2015 Q1	$3.84M	Buy	35,928 +76	+0.2%	+$7.24K	0.13%	171
2014 Q4	$3.37M	Sell	35,852 -19,540	-35%	-$1.86M	0.11%	177
2014 Q3	$4.25M	Buy	55,392 +720	+1%	+$56.7K	0.14%	168
2014 Q2	$4.91M	Sell	54,672 -3,010	-5%	-$184K	0.16%	170
2014 Q1	$3.09M	Buy	+57,682	New	+$1.9M	0.1%	190

Other funds holding PTX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Jupiter Asset Management's PTX Position: Q2 2016 in Review

Jupiter Asset Management sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2016, closing a stake of 100,865 shares — an estimated $1.06M sold.

Jupiter Asset Management first reported a position in PTX in Q1 2014 and held it in 9 quarters. The position peaked at $4.94M in Q2 2015. 56 funds tracked by Wall St. Rank hold PTX as of Q2 2016.

Jupiter Asset Management reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2016 after selling out during the quarter.
Jupiter Asset Management sold 100,865 Pernix Therapeutics Holdings, Inc. shares in Q2 2016, an estimated $1.06M.
Jupiter Asset Management first reported a position in Pernix Therapeutics Holdings, Inc. in Q1 2014 and held it in 9 quarters.
Jupiter Asset Management's Pernix Therapeutics Holdings, Inc. position peaked at $4.94M in Q2 2015.
56 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2016.

Based on Jupiter Asset Management's 13F filing for Q2 2016, filed 10 Aug 2016.